In addition, life-expectancy was adjusted for quality of life (i.e., Quality-Adjusted-Life Years (QALYs) using health-related quality-of-life weights (Table 2).
Prophylactic and therapeutic measures are needed to further increase life expectancy and quality for patients with CGD.
Understanding the process of early tumor development could be of great value, as cancer, if not cured, could become a controlled illness, reducing mortality rates and increasing life expectancy and quality for patients.
Lastly, the fact that output measures that are not adjusted for quality (life expectancy) are consistent substitutes for quality-adjusted output measures (DALY, QALY) means that cross-country analysis can still be conducted, while the OECD continues to develop, maintain, and produce these quality-adjusted output measures on a more consistent basis.
Life expectancy was also estimated accounting for quality of life (QoL), based on quality-adjusted life years (QALY).
The table also shows the increase in life expectancy, with and without adjustment for quality of life, for those who are candidates for each activity.
Venous flow to the pulmonary vasculature decreases cardiac volume load and is likely to increase life expectancy and quality of life for these patients.
Kidney transplantation offers a significant improvement in life expectancy and quality of life for patients with end stage renal disease[1].
Improvements in life expectancy and quality of life for HIV-positive women coupled with reduced vertical transmission will likely lead numerous HIV-positive women to consider becoming pregnant.
Life expectancy and quality of life for people with type 1 diabetes are limited by the development of vascular complications such as nephropathy, retinopathy and hypertension, not least because such vascular changes lead to kidney failure and blindness, cardiac disease, stroke and limb amputations [ 1].
